Table 2.

Distribution of patients in study groups

Parameters	Group 1	Group 2	Group 3 (without combined immunotherapy)
Total number of patients:	18		31
males	10		18
females	8		13
Mean age (years)	53.3	52	56.2
Karnofsky Performance Status at the beginning of combined immunotherapy (points), Me [25; 75]	60 [50; 70]	70 [70; 80]	60 [40; 80]